Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
92.26
+4.81 (5.50%)
Jul 21, 2026, 10:06 AM EDT - Market open

Twist Bioscience Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Buy" and an average price target of $85.5. The average 1-year stock price forecast is 7.33% lower than the current stock price, while the lowest is $36 (-60.98%) and the highest is $120 (+30.07%).

Price Target: $85.5 (-7.33%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$36$85.5$87$120
Change-60.98%-7.33%-5.70%+30.07%

Analyst Ratings

The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy777887
Buy111122
Hold222112
Sell000000
Strong Sell000000
Total101010101111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$90$120
BuyReiterates$90$120+30.07%Jul 14, 2026
Evercore ISI
Evercore ISI
Hold
Downgrades
$66$102
HoldDowngrades$66$102+10.56%Jul 6, 2026
Guggenheim
Guggenheim
Buy
Maintains
$60$107
BuyMaintains$60$107+15.98%Jun 29, 2026
Barclays
Barclays
Buy
Reiterates
$65$95
BuyReiterates$65$95+2.97%Jun 24, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$68$89
BuyReiterates$68$89-3.53%Jun 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
444.69M
from 376.57M
Increased by 18.09%
Revenue Next Year
519.96M
from 444.69M
Increased by 16.93%
EPS This Year
-0.77
from -2.12
EPS Next Year
-0.85
from -0.77
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
132.33M203.57M245.11M312.97M376.57M444.69M
Revenue Growth
46.87%53.83%20.41%27.69%20.32%18.09%
Gross Profit
51.71M84.24M89.73M133.35M191.00M231.90M
Gross Margin
39.08%41.38%36.61%42.61%50.72%52.15%
Operating Income
-153.26M-249.02M-206.90M-175.90M-136.26M-135.86M
Net Income
-152.10M-217.86M-204.62M-208.73M-77.67M-128.95M
EPS
-----2.12-0.77
Free Cash Flow
-73.09M-160.52M-112.43M-17.42M-32.63M-83.80M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High447.0M
Avg444.7M
Low428.9M

Revenue Growth

Revenue Growth202620272028
High
18.7%
Avg
18.1%
Low
13.9%

EPS Forecast

EPS202620272028
High-0.58
Avg-0.77
Low-0.96

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-